// App-Quantinova.ai

4000 : A DNA damage response deficiency (DDRD) group in breast cancer is associated with activation of the STING innate immune pathway and PD-L1 expression

Researchers

Presenter

  • Eileen E. Parkes

Principal Investigators

  • Steven M. Walker

  • Nuala McCabe

  • Laura E. Taggart

  • Laura Hill

  • Niamh E. Buckley

  • Kienan I. Savage

  • Manuel Salto-Tellez

  • Stephen McQuaid

  • Mary T. Harte

  • Paul B. Mullan

  • D Paul Harkin

  • Richard D. Kennedy

Medical Centers

  • Queen's University Belfast, Belfast, United Kingdom

  • Almac Diagnostics Ltd., Craigavon, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 4

  • Programmed death-ligand 1

  • Cluster of differentiation 8A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved